Isomorphic Labs
Miguel Gancedo Rodrigo is a Research Investigator specializing in In Vitro Pharmacology at Isomorphic Labs since October 2023. Previously, Miguel served as a Principal Scientist and Biology Project Leader at BenevolentAI, overseeing small molecule drug discovery projects from hit identification to preclinical development. Miguel's experience includes a role as a Senior Research Scientist at AstraZeneca, where Miguel contributed to Oncology and Neuroscience projects, and as a Laboratory Research Officer at The Francis Crick Institute, focusing on the kinetics of E. coli RecA recombinase. Miguel's education includes a Master's degree in Cancer Pharmacology from London Metropolitan University and a Master's in Pharmacy from Universidad de Murcia.
This person is not in any teams
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.